Plasma pentosidine levels are associated with prevalent fractures in patients with chronic liver disease.

Plasma pentosidine was significantly associated with prevalent fractures and liver functional reserve in patients with CLD. Pentosidine may be useful in predicting fracture risk and should be closely followed in CLD patients with advanced disease.